{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:07:20Z","timestamp":1789578440298,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korean government","award":["NRF-2020R1C1C1006121"],"award-info":[{"award-number":["NRF-2020R1C1C1006121"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01AG061811"],"award-info":[{"award-number":["R01AG061811"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The correlations between apolipoprotein epsilon 4 (APOE4) status and regional amyloid, tau, and cortical thickness in cognitively normal elderly are not fully understood. Our cross-sectional study aimed to compare regional amyloid\/tau burden, and cortical thickness according to APOE4 carrier status and assess correlations between APOE4 and Alzheimer\u2019s disease (AD)-related biomarker burdens. We analyzed 185 cognitively normal participants from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) cohort. Participants aged 55\u201390 with normal cognitive function were divided into amyloid \u00df-positive (A\u00df+) APOE4 carriers (group 1, n\u2009=\u200927), A\u00df+ APOE4 non-carriers (group 2, n\u2009=\u200929), and A\u00df\u2212 normal controls (group 0, n\u2009=\u2009129). We compared amyloid depositions, tau depositions, and cortical thickness among the three groups and assessed correlations between APOE4 existence and imaging biomarkers adjusted for age and sex. The participants in group 2 were older than those in the other groups. The regional amyloid\/tau standardized uptake value ratios (SUVRs) did not differ between groups 1 and 2, but the amyloid\/tau SUVRs in most regions were numerically higher after adjusting for age difference. APOE4 allele had robust correlations with increased amyloid burden in the fronto-temporo-parietal cortical areas after adjustment for age and sex, but it had weaker and mixed correlations with the regional tau burden and did not have significant correlation with cortical thickness. We identified that the presence of APOE4 allele might be more highly associated with amyloid deposition than with other AD-related biomarkers such as tau or cortical thickness in cognitively normal elderly.<\/jats:p>","DOI":"10.1038\/s41598-022-18325-2","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T13:05:44Z","timestamp":1661173544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals"],"prefix":"10.1038","volume":"12","author":[{"given":"Yun Jeong","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sepulcre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"18325_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"18325_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2012.04.017","volume":"34","author":"AS Fleisher","year":"2013","unstructured":"Fleisher, A. S. et al. Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol. Aging. 34, 1\u201312 (2013).","journal-title":"Neurobiol. Aging."},{"key":"18325_CR3","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis. JAMA 313, 1924\u20131938 (2015).","journal-title":"JAMA"},{"key":"18325_CR4","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/WNL.0000000000003234","volume":"87","author":"J Gonneaud","year":"2016","unstructured":"Gonneaud, J. et al. Relative effect of APOE \u03f54 on neuroimaging biomarker changes across the lifespan. Neurology 87, 1696\u20131703 (2016).","journal-title":"Neurology"},{"key":"18325_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkow, D. The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"18325_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"18325_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/cjn.2014.15","volume":"41","author":"ER Zimmer","year":"2014","unstructured":"Zimmer, E. R., Leuzy, A., Gauthier, S. & Rosa-Neto, P. Developments in tau PET imaging. Can. J. Neurol. Sci. 41, 547\u2013553 (2014).","journal-title":"Can. J. Neurol. Sci."},{"key":"18325_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","volume":"12","author":"S Emrani","year":"2020","unstructured":"Emrani, S., Arain, H. A., DeMarshall, C. & Nuriel, T. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer\u2019s disease: A systematic review. Alzheimers Res. Ther. 12, 141 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"18325_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson, K. A. et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann. Neurol. 79, 110\u2013119 (2016).","journal-title":"Ann. Neurol."},{"issue":"12","key":"18325_CR10","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jalz.2019.07.011","volume":"15","author":"OA Williams","year":"2019","unstructured":"Williams, O. A. et al. Apolipoprotein E epsilon4 allele effects on longitudinal cognitive trajectories are sex and age dependent. Alzheimers Dement. 15(12), 1558\u20131567 (2019).","journal-title":"Alzheimers Dement."},{"issue":"4","key":"18325_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jalz.2019.08.195","volume":"16","author":"V Ghisays","year":"2020","unstructured":"Ghisays, V. et al. Brain imaging measurements of fibrillar amyloid-beta burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE epsilon4 allele. Alzheimers Dement. 16(4), 598\u2013609 (2020).","journal-title":"Alzheimers Dement."},{"issue":"10","key":"18325_CR12","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1038\/s41380-020-0688-6","volume":"26","author":"J Therriault","year":"2021","unstructured":"Therriault, J. et al. Alzheimer\u2019s disease neuroimaging initiative APOE epsilon4 potentiates the relationship between amyloid-beta and tau pathologies. Mol. Psychiatry. 26(10), 5977\u20135988 (2021).","journal-title":"Mol. Psychiatry."},{"issue":"4","key":"18325_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault, J. et al. Association of apolipoprotein E \u03b54 with medial temporal tau independent of amyloid-\ua7b5. JAMA Neurol. 77(4), 470\u2013479 (2020).","journal-title":"JAMA Neurol."},{"key":"18325_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-Mental State\u201d: A practical method for grading cognitive state of patients for the clinicians. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"18325_CR15","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The clinical dementia rating (CDR): Current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"issue":"11","key":"18325_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen, W. G., Mohs, R. C. & Davis, K. L. A new rating scale for Alzheimer\u2019s disease. Am. J. Psychiatry. 141(11), 1356\u20131364 (1984).","journal-title":"Am. J. Psychiatry."},{"issue":"4","key":"18325_CR17","first-page":"695","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. MoCA: A brief screening tool for mild cognitive impairment. Can. J. Neurol. Sci. 53(4), 695\u2013699 (2005).","journal-title":"Can. J. Neurol. Sci."},{"key":"18325_CR18","volume-title":"L\u2019examen Clinique en Psychologie","author":"A Rey","year":"1964","unstructured":"Rey, A. L\u2019examen Clinique en Psychologie (Presses Universitaires de France, 1964)."},{"issue":"3","key":"18325_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H., Chance, J. M. & Filos, S. Measurement of functional activities in older adults in the community. J. Gerontol. 37(3), 323\u2013329 (1982).","journal-title":"J. Gerontol."},{"key":"18325_CR20","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings, J. L. The neuropsychiatric inventory: Assessing psychopathology in dementia patients. Neurology 48, S10\u2013S16 (1997).","journal-title":"Neurology"},{"key":"18325_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3233\/JAD-150729","volume":"51","author":"C Rattanabannakit","year":"2016","unstructured":"Rattanabannakit, C. et al. The cognitive change index as measure of self and informant perception of cognitive decline: Relation to neuropsychological tests. J. Alzheimers Dis. 51, 1145\u20131155 (2016).","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"18325_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale, A. M., Fischl, B. & Sereno, M. I. Cortical surface-based analysis I. Segmentation and surface reconstruction. Neuroimage 9(2), 179\u2013194 (1999).","journal-title":"Neuroimage"},{"issue":"3","key":"18325_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31(3), 968\u2013980 (2006).","journal-title":"Neuroimage"},{"issue":"1","key":"18325_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer, N. et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15(1), 273\u2013289 (2002).","journal-title":"Neuroimage"},{"issue":"12","key":"18325_CR25","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41591-018-0206-4","volume":"24","author":"J Sepulcre","year":"2018","unstructured":"Sepulcre, J. et al. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex. Nat. Med. 24(12), 1910\u20131918 (2018).","journal-title":"Nat. Med."},{"issue":"3","key":"18325_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2967\/jnumed.111.090340","volume":"53","author":"AD Joshi","year":"2012","unstructured":"Joshi, A. D. et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer\u2019s disease and cognitively normal subjects. J. Nucl. Med. 53(3), 378\u2013384 (2012).","journal-title":"J. Nucl. Med."},{"issue":"1","key":"18325_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B Stat. Methodol. 57(1), 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B Stat. Methodol."},{"key":"18325_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","volume":"13","author":"CR Jack Jr","year":"2014","unstructured":"Jack, C. R. Jr. et al. Age-specific population frequencies of cerebral betaamyloidosis and neurodegeneration among people with normal cognitive function aged 50\u201389 years: A cross-sectional study. Lancet Neurol. 13, 997\u20131005 (2014).","journal-title":"Lancet Neurol."},{"issue":"1","key":"18325_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/brain\/awx320","volume":"141","author":"VJ Lowe","year":"2018","unstructured":"Lowe, V. J. et al. Widespread brain tau and its association with ageing Braak stage and Alzheimer\u2019s dementia. Brain 141(1), 271\u2013287 (2018).","journal-title":"Brain"},{"issue":"10","key":"18325_CR30","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2967\/jnumed.117.204271","volume":"59","author":"VJ Lowe","year":"2018","unstructured":"Lowe, V. J. et al. White matter reference region in PET studies of 11C-Pittsburgh compound B Uptake: Effects of age and amyloid-\u03b2 deposition. J. Nucl. Med. 59(10), 1583\u20131589 (2018).","journal-title":"J. Nucl. Med."},{"key":"18325_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18325-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T07:20:43Z","timestamp":1727853643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18325"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18325-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"30 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14307"}}